Report Detail
Global Chronic Urticaria Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4771495 |
- 06 November, 2026 |
- Global |
- 106 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Chronic Urticaria Medicine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Chronic Urticaria Medicine refers to the specific medications used in the management of chronic urticaria, also known as chronic hives,Mainly including Antihistamines,H2 Antagonists,Leukotriene Receptor Antagonists,Corticosteroids,Immunosuppressant and Biologics.
This report is a detailed and comprehensive analysis for global Chronic Urticaria Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chronic Urticaria Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chronic Urticaria Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chronic Urticaria Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chronic Urticaria Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Urticaria Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Urticaria Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Merck, Fresenius, 3SBIO, SPHBIO, Sun Pharmaceutical Industries, Yangtze River Pharmaceutical Group, CSPC Pharmaceutical Group, Shanxi C&Y Pharmaceutical Group, Lianhuan Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chronic Urticaria Medicine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Loratadine
Desloratadine
Fexofenadine
Ebastine
Stastine
Cetirizine
Levocetirizine
Cinnarizine
Other
Market segment by Application
Hospital and Clinic
Specialist Medical Centre
Retail Pharmacies
Other
Major players covered
Johnson & Johnson
Merck
Fresenius
3SBIO
SPHBIO
Sun Pharmaceutical Industries
Yangtze River Pharmaceutical Group
CSPC Pharmaceutical Group
Shanxi C&Y Pharmaceutical Group
Lianhuan Pharma
Jiudian Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Urticaria Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chronic Urticaria Medicine, with price, sales quantity, revenue, and global market share of Chronic Urticaria Medicine from 2021 to 2026.
Chapter 3, the Chronic Urticaria Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Urticaria Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Chronic Urticaria Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Urticaria Medicine.
Chapter 14 and 15, to describe Chronic Urticaria Medicine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Chronic Urticaria Medicine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Loratadine
- 1.3.3 Desloratadine
- 1.3.4 Fexofenadine
- 1.3.5 Ebastine
- 1.3.6 Stastine
- 1.3.7 Cetirizine
- 1.3.8 Levocetirizine
- 1.3.9 Cinnarizine
- 1.3.10 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Chronic Urticaria Medicine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital and Clinic
- 1.4.3 Specialist Medical Centre
- 1.4.4 Retail Pharmacies
- 1.4.5 Other
- 1.5 Global Chronic Urticaria Medicine Market Size & Forecast
- 1.5.1 Global Chronic Urticaria Medicine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Chronic Urticaria Medicine Sales Quantity (2021-2032)
- 1.5.3 Global Chronic Urticaria Medicine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Johnson & Johnson
- 2.1.1 Johnson & Johnson Details
- 2.1.2 Johnson & Johnson Major Business
- 2.1.3 Johnson & Johnson Chronic Urticaria Medicine Product and Services
- 2.1.4 Johnson & Johnson Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Johnson & Johnson Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck Chronic Urticaria Medicine Product and Services
- 2.2.4 Merck Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 Fresenius
- 2.3.1 Fresenius Details
- 2.3.2 Fresenius Major Business
- 2.3.3 Fresenius Chronic Urticaria Medicine Product and Services
- 2.3.4 Fresenius Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Fresenius Recent Developments/Updates
- 2.4 3SBIO
- 2.4.1 3SBIO Details
- 2.4.2 3SBIO Major Business
- 2.4.3 3SBIO Chronic Urticaria Medicine Product and Services
- 2.4.4 3SBIO Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 3SBIO Recent Developments/Updates
- 2.5 SPHBIO
- 2.5.1 SPHBIO Details
- 2.5.2 SPHBIO Major Business
- 2.5.3 SPHBIO Chronic Urticaria Medicine Product and Services
- 2.5.4 SPHBIO Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 SPHBIO Recent Developments/Updates
- 2.6 Sun Pharmaceutical Industries
- 2.6.1 Sun Pharmaceutical Industries Details
- 2.6.2 Sun Pharmaceutical Industries Major Business
- 2.6.3 Sun Pharmaceutical Industries Chronic Urticaria Medicine Product and Services
- 2.6.4 Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
- 2.7 Yangtze River Pharmaceutical Group
- 2.7.1 Yangtze River Pharmaceutical Group Details
- 2.7.2 Yangtze River Pharmaceutical Group Major Business
- 2.7.3 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product and Services
- 2.7.4 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
- 2.8 CSPC Pharmaceutical Group
- 2.8.1 CSPC Pharmaceutical Group Details
- 2.8.2 CSPC Pharmaceutical Group Major Business
- 2.8.3 CSPC Pharmaceutical Group Chronic Urticaria Medicine Product and Services
- 2.8.4 CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
- 2.9 Shanxi C&Y Pharmaceutical Group
- 2.9.1 Shanxi C&Y Pharmaceutical Group Details
- 2.9.2 Shanxi C&Y Pharmaceutical Group Major Business
- 2.9.3 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product and Services
- 2.9.4 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
- 2.10 Lianhuan Pharma
- 2.10.1 Lianhuan Pharma Details
- 2.10.2 Lianhuan Pharma Major Business
- 2.10.3 Lianhuan Pharma Chronic Urticaria Medicine Product and Services
- 2.10.4 Lianhuan Pharma Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Lianhuan Pharma Recent Developments/Updates
- 2.11 Jiudian Pharmaceutical
- 2.11.1 Jiudian Pharmaceutical Details
- 2.11.2 Jiudian Pharmaceutical Major Business
- 2.11.3 Jiudian Pharmaceutical Chronic Urticaria Medicine Product and Services
- 2.11.4 Jiudian Pharmaceutical Chronic Urticaria Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Jiudian Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Chronic Urticaria Medicine by Manufacturer
- 3.1 Global Chronic Urticaria Medicine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Chronic Urticaria Medicine Revenue by Manufacturer (2021-2026)
- 3.3 Global Chronic Urticaria Medicine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Chronic Urticaria Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Chronic Urticaria Medicine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Chronic Urticaria Medicine Manufacturer Market Share in 2025
- 3.5 Chronic Urticaria Medicine Market: Overall Company Footprint Analysis
- 3.5.1 Chronic Urticaria Medicine Market: Region Footprint
- 3.5.2 Chronic Urticaria Medicine Market: Company Product Type Footprint
- 3.5.3 Chronic Urticaria Medicine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Chronic Urticaria Medicine Market Size by Region
- 4.1.1 Global Chronic Urticaria Medicine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Chronic Urticaria Medicine Consumption Value by Region (2021-2032)
- 4.1.3 Global Chronic Urticaria Medicine Average Price by Region (2021-2032)
- 4.2 North America Chronic Urticaria Medicine Consumption Value (2021-2032)
- 4.3 Europe Chronic Urticaria Medicine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Chronic Urticaria Medicine Consumption Value (2021-2032)
- 4.5 South America Chronic Urticaria Medicine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Chronic Urticaria Medicine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Chronic Urticaria Medicine Sales Quantity by Type (2021-2032)
- 5.2 Global Chronic Urticaria Medicine Consumption Value by Type (2021-2032)
- 5.3 Global Chronic Urticaria Medicine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Chronic Urticaria Medicine Sales Quantity by Application (2021-2032)
- 6.2 Global Chronic Urticaria Medicine Consumption Value by Application (2021-2032)
- 6.3 Global Chronic Urticaria Medicine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Chronic Urticaria Medicine Sales Quantity by Type (2021-2032)
- 7.2 North America Chronic Urticaria Medicine Sales Quantity by Application (2021-2032)
- 7.3 North America Chronic Urticaria Medicine Market Size by Country
- 7.3.1 North America Chronic Urticaria Medicine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Chronic Urticaria Medicine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Chronic Urticaria Medicine Sales Quantity by Type (2021-2032)
- 8.2 Europe Chronic Urticaria Medicine Sales Quantity by Application (2021-2032)
- 8.3 Europe Chronic Urticaria Medicine Market Size by Country
- 8.3.1 Europe Chronic Urticaria Medicine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Chronic Urticaria Medicine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Urticaria Medicine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Chronic Urticaria Medicine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Chronic Urticaria Medicine Market Size by Region
- 9.3.1 Asia-Pacific Chronic Urticaria Medicine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Chronic Urticaria Medicine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Chronic Urticaria Medicine Sales Quantity by Type (2021-2032)
- 10.2 South America Chronic Urticaria Medicine Sales Quantity by Application (2021-2032)
- 10.3 South America Chronic Urticaria Medicine Market Size by Country
- 10.3.1 South America Chronic Urticaria Medicine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Chronic Urticaria Medicine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Urticaria Medicine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Chronic Urticaria Medicine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Chronic Urticaria Medicine Market Size by Country
- 11.3.1 Middle East & Africa Chronic Urticaria Medicine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Chronic Urticaria Medicine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Chronic Urticaria Medicine Market Drivers
- 12.2 Chronic Urticaria Medicine Market Restraints
- 12.3 Chronic Urticaria Medicine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Chronic Urticaria Medicine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Chronic Urticaria Medicine
- 13.3 Chronic Urticaria Medicine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Chronic Urticaria Medicine Typical Distributors
- 14.3 Chronic Urticaria Medicine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Chronic Urticaria Medicine. Industry analysis & Market Report on Chronic Urticaria Medicine is a syndicated market report, published as Global Chronic Urticaria Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Chronic Urticaria Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
